Escozine HP (Medolife Corporation)


Welcome to the PulseAid listing for the Escozine HP drug offered from Medolife Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Medolife Corporation
NON-PROPRIETARY NAME: RHOPALURUS PRINCEPS VENOM, Bryonia Alba,Echinacea purpurea
SUBSTANCE NAME: ECHINACEA PURPUREA; BRYONIA ALBA ROOT; RHOPALURUS PRINCEPS VENOM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-09-30
END MARKETING DATE: 0000-00-00


Escozine HP HUMAN OTC DRUG Details:

Item DescriptionEscozine HP from Medolife Corporation
LABELER NAME: Medolife Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 10; 30; 3([hp_X]/mL; [hp_C]/mL; [hp_X]/mL)
START MARKETING DATE: 2016-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70891-201_3b429454-a71b-68ba-e054-00144ff8d46c
PRODUCT NDC: 70891-201
APPLICATION NUMBER:

Other ECHINACEA PURPUREA; BRYONIA ALBA ROOT; RHOPALURUS PRINCEPS VENOM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Medolife CorporationEscozine HP